ISPUB.com / IJH/14/1/21103
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Health
  • Volume 14
  • Number 1

Original Article

New Evidence On Breast Cancer Risk Factors In Greece – A Cross Sectional Case Control Study

G Anthimidis, C Kosmidis, C Efthimiadis, K Vasiliadou, G Ioannidou, B Papaziogas, E Fahantidis

Keywords

breast cancer, risk factors

Citation

G Anthimidis, C Kosmidis, C Efthimiadis, K Vasiliadou, G Ioannidou, B Papaziogas, E Fahantidis. New Evidence On Breast Cancer Risk Factors In Greece – A Cross Sectional Case Control Study. The Internet Journal of Health. 2014 Volume 14 Number 1.

Abstract

Objective: Epidemiological studies on factors implicated in pathogenesis of breast cancer reveal international variations. The aim of this study was to identify the actual risk factors among Greek women in Macedonia.

Design: A cross-sectional case-control study among women with or without breast cancer was prospectively conducted in outpatient breast department of two surgical clinics of Thessaloniki.

Materials and Method: Fifty three histopathologically confirmed breast cancer cases were included. The control group consisted of 131 women. Data were collected by a face to face interview using a questionnaire consisting of 33 questions. Statistical adjustment was rendered more efficient by matching cases and controls in groups, choosing a control group (n=75) with an age distribution similar to that of the cases (n=53).

Statistical comparisons were performed using logistic regression analysis, to compute the odds ratios (ORs) for the variables of interest.

Results: Differences in distribution of age at first live birth were found between cases (Median age: 25 years, Range: 22 years) and controls (Median age: 22 years, Range: 35 years), p=0,021, Odds ratio= 1,086. All of the rest key risk factors were interestingly found to have no significant effect in breast cancer risk.

Conclusion: We did not find any statistical relationship between key risk factors and development of breast cancer, except for age at first live birth. Our miscellaneous results may be due to specific characteristics of our study population.  Further studies are required to test the consistency of our findings in larger sample sizes and hopefully in other study populations.

 

Introduction

Breast cancer is the most common cancer worldwide for women, with more than 1.676.000 new cases diagnosed in 2012. There is a nearly four-fold variation in the incidence of the disease reported among different countries.1 Identification of factors responsible for increasing the chance of breast cancer developing is important in daily clinical practice. Numerous epidemiological studies on these risk factors have produced evidence on international variations. These studies are limited among women of less-industrialized countries, including Greece. Therefore, we aimed to assess various factors implicated in the aetiology of breast cancer to identify the actual risk factors among Greek women in Macedonia, so as to develop appropriate clinical practice guidelines and hopefully prevention strategies.

Materials and Methods

Between January 2008 and December 2010, a university hospital cross-sectional case-control study among Greek women with or without breast cancer was conducted. The survey was prospectively carried out among women in outpatient breast department of two surgical clinics of Thessaloniki (Hippokratio and AHEPA, Aristotle University of Thessaloniki) by using a questionnaire. The source population was a group of subjects that visited the outpatient breast department, consisting of 234 women. Fifty three histopathologically confirmed breast cancer cases were included. The control group consisted of 131 women without clinical evidence of breast cancer at the time of the study. The remaining 50 women could be clearly regarded neither as cases nor as controls.  An institutional ethical committee approval was obtained before starting with the study. All interviews were conducted at the hospital. Data were collected by a face to face interview using a questionnaire form after having the informed consents of the participants. The questionnaire consisted of 33 questions related to potential risk factors.  These included: a) general characteristics of women: age, body mass index (BMI), weight (and BMI) difference after the age of 18 years old, after menopause and in the last 5 years, smoking, alcohol consumption, b) menstrual and reproductive history: exogenous hormone exposure (use of hormone replacement therapy, oral contraceptive pills), age at menarche and menopause, parity, age at first live birth, breast feeding, c) family history of breast cancer: number of affected first degree relatives (mothers, sisters, daughters), number of affected second degree relatives, and significant characteristics of their disease (age of onset, menopausal status, bilaterality, and presence of associated cancer, specifically ovarian, colon, prostate, pancreatic, gallbladder, bile duct, and stomach cancers, as well as melanoma), d) breast imaging: history of false positive mammography, breast density [using the American College of Radiology Breast Imaging-Reporting and Data System (BI-RADS) density categories: almost entirely fat (category 1), scattered fibroglandular densities (category 2), heterogeneously dense (category 3), and extremely dense (category 4)], e) number of previous biopsies and histologic risk factors, specifically, Atypical ductal hyperplasia, Atypical lobular hyperplasia, Lobular carcinoma in situ, Ductal carcinoma in situ, and f) bone density, history of spontaneous fracture and height loss. The data was stored by using Microsoft Access program.

Statistical analysis

All data were recorded using the Statistical Package for Social Sciences (SPSS) 21 for Windows for statistical analyses. Data were tabulated comparing cases with controls according to the risk factors.

Descriptive statistics were compiled to characterize the study population and to examine case-control differences. Potential risk factors were compared between cases and controls by the Chi-square Test for Independence for categorical variables and utilizing the methodology of the Independent Samples T-Test for continuous variables or Mann-Whitney U Test for continuous variables without normal distribution. Statistical comparisons were performed using Binary logistic regression analysis (BLRA), which was carried out to compute the odds ratios (ORs) for the variables of interest. P values below 0.05 were considered to be significant.

Statistical adjustment was rendered more efficient by matching cases and controls in groups, choosing a control group (n=75) with an age distribution similar to that of the cases (n=53).

Moreover, several variables were revised as categorical dichotomous variables, specifically: affected first-degree relatives (presence/absence, instead of number of first-degree relatives with history of breast cancer), affected second-degree relatives (presence/absence, instead of number of second-degree relatives with history of breast cancer), menopausal status of affected first-degree relatives (pre/post menopausal, or else negative/positive for menopause), menopausal status of affected second-degree relatives (pre/post menopausal, otherwise negative/positive for menopause), bilateral disease in first-degree relatives with history of breast cancer (negative/positive), bilateral disease in second-degree relatives with history of breast cancer (negative/positive), first-degree relatives with history of breast cancer along with associated cancer (negative/positive), parity (never/ever, instead of number of offspring), breastfeeding (never/ever, instead of weeks of lactation, which was also worked out as a discrete variable), history of previous breast biopsy (never/ever, instead of number of previous biopsies), history of benign breast disease, particularly atypical hyperplasia  (presence/absence), history of non infiltrative breast cancer (presence/absence), history of false positive mammography (positive/negative), breast density [most dense breasts (higher percentage of non-fatty tissue/least dense breasts, instead of classic BI-RADS density categories), smoking (current or former active smokers/never smokers, instead of number of cigarettes per day), alcohol consumption (heavy or light drinkers/non-drinkers, instead of units of alcohol per day or per week), exogenous hormone exposure: use of hormone replacement therapy, oral contraceptive pills (never/ever), bone density (normal/abnormal),  history of spontaneous fracture (positive/negative), nation (Greek/other).

Continuous variables were measured in units of kg/m2 for BMI and discrete variables were also measured in years for age and in weeks for lactation.

Results

Comparison of patients with breast cancer (n = 53) and control cases (n = 75) according to risk factors are summarized in Table 1 for continuous/discrete variables without normal distribution and in Table 2 for variables with normal distribution. Moreover categorical variables that do not violate the assumption of the Chi-square Test for Independence concerning the “minimum cell frequency” (at least 80% of cells with expected frequencies of 5 or more) are presented in Table 3. Finally, comparison of groups for categorical variables that do violate the assumption of the Chi-square Test concerning the “minimum cell frequency” is shown in Table 4, using Fisher’s Exact Probability Test.

Differences in distribution of age at first live birth were found out between cases and controls with a slight excess of younger control subjects. Thus, median age at first live birth of the controls was 22 years (Range: 35 years) and 25 years for the cases (Range: 22 years); p=0,021, Odds ratio= 1,086.

No difference was apparent between study groups in body mass index (BMI), in weight gain after the age of 18 years old, after menopause, and in the last 5 years, in smoking, alcohol consumption, menstrual and reproductive history [exogenous hormone exposure (use of hormone replacement therapy, oral contraceptive pills), age at menarche and menopause, parity, (duration of) breast feeding)] and family history of breast cancer (first degree relatives with history of breast cancer and their age at diagnosis, premenopausal onset and bilateral breast cancer or  breast and other associated cancer, and second degree relatives with history of breast cancer and their age at diagnosis, premenopausal onset and bilateral breast cancer), bone density, history of spontaneous fracture and height loss, breast density, history of false positive mammography, performance of previous biopsies, histologic risk factors (atypical hyperplasia, non infiltrative cancer). 

Discussion

Because of the multifactorial process in breast cancer development, and the tendency for lifestyle variables to cluster, inconsistent and inconclusive data have emerged on breast cancer risk even from well-designed epidemiological research. Consequently, it is essential to continuously update knowledge on the risk factors and their impact on breast cancer. This could help women make beneficial changes in their behavior that could reduce their breast cancer risk. It is interesting that evidence suggests that more than 50% of cancer incidence could be prevented if knowledge of risk factors was applied to changes in behavior.2

The present case-control study provides results on risk factors and breast cancer among Greek women in Macedonia. To our knowledge, this is the first epidemiological investigation to assess the possible role of the key risk factors in the etiology of breast cancer in such a sample.

Our findings concur with previous work reporting that young age at first full term pregnancy and live birth has a protective effect.3,4  Late age at first birth delays terminal duct proliferation of mammary gland, probably leading to a higher proportion of epithelial cells that are susceptible to carcinogenic insult.5

In the present study it was interesting to discover that the whole of the rest key risk factors were found to have no significant effect in breast cancer risk.

We are aware that our research, like all other case-control studies, is subject to certain limitations. Potential biases such as selection biases (non response bias, hospital based bias), and information bias (interview bias, recall bias, reporting bias). Certainly, it is not always possible to attain complete and accurate family history data, whether because of time restrictions or because of family matters such as premature deaths, small family size, and distant or broken families. However, while recall bias are acknowledged, such a setback is expected to be minimized since the same process served to collect information from cases and controls. Furthermore, the probability of obtaining false information on lifetime weight and respective age may be not as much of, as weight gain is a continuous concern for a majority of women, and they can recall their weight and its timing fairly correctly.6 Yet, as with most case-control studies, selection and recall bias may have influenced our results.

In addition, the sample size is not large, but it is estimated to provide a confidence level of 95% with a conventional margin of error of 8,63%. (7,8,9,10). Besides, the hospitals where the survey was conducted are the busiest hospitals located in Thessaloniki, and over 80% of the outpatients reside in Thessaloniki which is the biggest city in Macedonia with a population of 1 million. The hospitals accept new outpatients with or without doctor's referral. Therefore, the outpatient population may be considered to reflect a general outpatient population of any hospital in Thessaloniki.

Our study is not the first to present divergent results. Several epidemiological studies on breast cancer risk factors have revealed variations among different nations.11 This may in fact be the reason why the International Agency for Research on Cancer (IARC) and the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) evaluations, which are the gold standard of cancer epidemiology, refer to certain risk factors as of limited or probable evidence, eg. hormone replacement therapy and tobacco smoking.12,13

The discrepancy between our findings and other studies in the literature might be due to different characteristics of Greek women that merit additional exploration. Environmental, geographical, dietary, genetic predisposition or personal factors that were not included in our study may be responsible for the interestingly peculiar results of our study.

In particular, potential risk factors that were not explored include: endogenous hormone exposure,14,15,16 physical activity,13,17,18,19 exposure to environmental tobacco smoke,20,21,22,23,24 occupational exposure to night shift work,12,25-34 medical conditions and treatments: use of digoxin,12,35-37 diabetes and use of metformin/pioglitazone,38-44 autoimmune thyroiditis,45 use of biphosphonates to treat low bone mineral density,46 use of aspirin or other non-steroidal anti-inflammatory drugs.47-50

Nevertheless, a possible explanation of our miscellaneous results might be reflected by a key statistic fact of breast cancer. Notably the age-standardized incidence rates for breast cancer in Greece, along with Bosnia Herzegovina, are the lowest in Europe.51 This variation, in distinction to other countries, may reflect different prevalence of risk and/or protective factors, since European countries almost certainly use similar, standardized diagnostic tests and screening methods. Since most risk factors were found to have no significant effect in breast cancer development, a special protective factor may account at least in part for our miscellaneous results. One specific characteristic of Greek women may be adherence to the Mediterranean diet. It is widely accepted that diet plays an important role in breast cancer prevention or progression and that dietary modification can induce beneficial effects against breast cancer.52-57

Unfortunately the dietary pattern was not investigated in the current report. This proved to be an important weakness of our study, since diet is a modifiable factor, which could be used as a protective choice.

However, a future research suggestion arises out of the research limitations that we have identified in our own critical assessment. 

Conclusion

Although certain factors are considered to be key factors in the development of breast cancer, we could not find any statistical relationship between these factors and risk of breast cancer, except for age at first live birth.

Our miscellaneous results may be due to specific characteristics of our study population.  Further studies are required to test the consistency of our findings in larger sample sizes and hopefully in other study populations.

Table 1
Comparison of patients with breast cancer (n = 53) and control cases (n = 75) according to risk factors

Table 2
Comparison of patients with breast cancer and control cases according to risk factors (variables) with normal distribution.

Table 3
Comparison of patients with breast cancer and control cases according to risk factors (categorical variables) that do not violate the assumption of the Chi-square Test for Independence concerning the “minimum cell frequency”.

Table 4
Comparison of patients with breast cancer and control cases according to risk factors (categorical variables) that do violate the assumption of the Chi-square Test for Independence concerning the “minimum cell frequency”.

References

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed September 2014.
2. Colditz GA, DeJong W, Hunter DJ, Trichopoulos D, Willett WC, eds. Harvard report on cancer prevention. Cancer Causes & Control;1996 7(1):1–55.
3. Rosner B, Colditz GA, Willett WC. Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study. Am J Epidemiol 1994;139(8):819-35.
4. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease. Lancet 2002;360(9328):187-95.
5. Shantakumar S, Terry MB, Teitelbaum SL, et al. Reproductive factors and breast cancer risk among older women. Breast Cancer Res Treat 2007;102:365-374.
6. Nkondjock A, Robidoux A, Paredes Y, Narod S, and Ghadirian P. Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians. Breast Cancer Research and Treatment, 2006;98(3):285–294.
7. Hamburg M. Basic Statistics: A Modern Approach. 3rd ed. Harcourt Brace Jovanovich, 1985.
8. Lang T, Secic M. How to Report Statistics in Medicine: Annotated Guidelines for Authors, Editors and Reviewers (Acp Information Technology Series). Philadelphia,Pennsylvania: American College of Physicians, 1997.
9. Rea L, Parker M. Designing and Conducting Survey Research: A Comprehensive Guide. 3rd Ed. San Francisco: Jossey Bass Public Administration Series, 2005.
10. Kish L. Survey Sampling. New ed. U.S.A: Wiley Classics Library, 1995.
11. Ozmen V, Ozcinar B, Karanlik H, et al. Breast cancer risk factors in Turkish women--a University Hospital based nested case control study. World J Surg Oncol 2009;7:37
12. International Agency for Research on Cancer. List of Classifications by cancer sites with sufficient or limited evidence in humans. Volumes 1 to 105. Available from http: //monographs.iarc.fr/ENG/Classification/index.php. Accessed September 2014.
13. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: AICR, 2007.
14. Endogenous Hormones Breast Cancer Collaborative Group. Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer 2011;105 (5):709-22.
15. Sieri S, Krogh V, Bolelli G, et al. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2009;18:169-176.
16. The Endogenous Hormones and Breast Cancer Collaborative Group. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010;11(6):530-42.
17. Wu Y, Zhang D, Kang S. Physical activity and risk of breast cancer: a meta-analysis of prospective studies. Breast Cancer Res Treat 2013;137:869-882.
18. Parkin DM. Cancers attributable to inadequate physical exercise in the UK in 2010. Br J Cancer 2011;105(2):38-41.
19. Friedenreich CM, Neilson HK, Lynch BM. State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 2010;46(14):2593-604.
20. Pirie K, Beral V, Peto R, et al. Passive smoking and breast cancer in never smokers: prospective study and meta- analysis. Int J Epidemiol 2008;37(5):1069-79.
21. Luo J, Margolis KL, Wactawski-Wende J, et al. Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study. BMJ 2011;342.
22. Reynolds P, Goldberg D, Hurley S, et al. Passive Smoking and Risk of Breast Cancer in the California Teachers Study. Cancer Epidem Biomar Prev 2009;18(12):3389-98.
23. Yang Y, Zhang F, Skrip L, et al. Lack of an Association between Passive Smoking and Incidence of Female Breast Cancer in Non-Smokers: Evidence from 10 Prospective Cohort Studies. PLoS ONE 2013;8(10):e77029.
24. Dossus L, Boutron-Ruault MC, Kaaks R, et al. Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort. Int J Cancer. 2014;134(8):1871-88.
25. Parkin DM. Cancers attributable to occupational exposures in the UK in 2010. Br J Cancer 2011;105(2):70-72.
26. Slack R, Young C, Rushton L. Occupational cancer in Britain. Br J Cancer 2012;107(1):27-32.
27. Stevens RG, Blask DE, Brainard GC, et al. Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect 2007;115(9):1357-62.
28. Schernhammer ES, Hankinson SE. Urinary Melatonin Levels and Postmenopausal Breast Cancer Risk in the Nurses' Health Study Cohort. Cancer Epidem Biomar Prev 2009;18(1):74-79.
29. Jia YJ, Lu YS, Wu KJ, et al. Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studies. Cancer Epidemiol. 2013;37(3):197-206.
30. Kolstad HA. Nightshift work and risk of breast cancer and other cancers - a critical review of the epidemiologic evidence. Scand. J. Work Environ. Health 2008;34(1):5-22.
31. Wang F, Yeung KL, Chan WC, et al. A meta-analysis on dose-response relationship between night shift work and the risk of breast cancer. Ann Oncol 2013;24(11):2724-32.
32. Kamdar BB, Tergas AI, Mateen FJ, et al. Night- shift work and risk of breast cancer: a systematic review and meta- analysis. Breast Cancer Res Treat 2013;138(1):291-301.
33. Megdal SP, Kroenke CH, Laden F, et al. Night work and breast cancer risk: A systematic review and meta-analysis. Eur J Cancer 2005;41(13):2023-32.
34. Buja A, Mastrangelo G, Perissinotto E, et al. Cancer incidence among female flight attendants: a meta-analysis of published data. J Womens Health (Larchmt) 2006;15(1):98-105.
35. Ahern T, Lash T, Sorensen H, et al. Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study. Breast Cancer Res 2008;10(6):102.
36. Biggar RJ, Wohlfahrt J, Oudin A, et al. Digoxin Use and the Risk of Breast Cancer in Women. J Clin Oncol 2011;29(16):2165-70.
37. Ahern TP, Tamimi RM, Rosner BA, Hankinson SE. Digoxin use and risk of invasive breast cancer: evidence from the Nurses' Health Study and meta-analysis. Breast Cancer Res Treat 2014;144(2):427-35.
38. De Bruijn KM, Arends LR, Hansen BE, et al. Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer. Br J Surg. 2013;100(11):1421-9.
39. Boyle P, Boniol M, Koechlin A, et al. Diabetes and breast cancer risk: a meta-analysis. Br J Cancer 2012;107(9):1608- 17.
40. Starup-Linde J, Karlstad O, Eriksen SA, et al. CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants- a Systematic Review and a Meta-Analysis. Curr Drug Saf 2013;8(5):296-332.
41. Monami M, Dicembrini I, Mannucci E. Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials. Acta Diabetol 2013;51(1):91-101.
42. Colmers IN, Bowker SL, et al. Thiazolidinedione use and cancer incidence in type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab 2012;38(6):475-84.
43. Col NF, Ochs L, Springmann V, et al. Metformin and breast cancer risk: a meta-analysis and critical literature review. Breast Cancer Res Treat 2012;135(3):639-46.
44. Zhang P, Li H, Tan X, et al. Association of metformin use with cancer incidence and mortality: a meta-analysis. Cancer Epidemiol 2013;37(3):207-18.
45. Hardefeldt PJ, Eslick GD, Edirimanne S. Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat. 2012;133(3):1169-77.
46. Liu Y, Zhao S, Chen W, et al. Bisphosphonate use and the risk of breast cancer: a meta-analysis of published literature. Clin Breast Cancer. 2012;12(4):276-81.
47. Takkouche B, Regueira-Méndez C, Etminan M. Breast Cancer and Use of Nonsteroidal Anti-inflammatory Drugs: A Meta- analysis. J Natl Cancer Inst 2008;100(20):1439-47.
48. Luo T, Yan H-M, He P, et al. Aspirin use and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2012;131(2):581-87.
49. Mangiapane S, Blettner M, Schlattmann P. Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005. Pharmacoepidem Drug Saf 2008;17(2):115-24.
50. Gates MA, Tworoger SS, Eliassen AH, et al. Analgesic Use and Sex Steroid Hormone Concentrations in Postmenopausal Women. Cancer Epidem Biomar Prev 2010;19(4):1033- 41.
51. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed 17/9/2014.
52. Aragón F, Perdigón G, de Moreno de LeBlanc A. Modification in the diet can induce beneficial effects against breast cancer. World J Clin Oncol 2014;5(3):455-64.
53. Castelló A, Pollán M, Buijsse B, et al. Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case-control EpiGEICAM study. Br J Cancer 2014. doi: 10.1038/bjc.2014.434. [Epub ahead of print]
54. de Lorgeril M, Salen P. Do statins increase and Mediterranean diet decrease the risk of breast cancer? BMC Med 2014;12:94.
55. Mourouti N, Kontogianni MD, Papavagelis C. Adherence to the Mediterranean diet is associated with lower likelihood of breast cancer: a case-control study. Nutr Cancer 2014;66(5):810-7.
56. Albuquerque RC, Baltar VT, Marchioni DM. Breast cancer and dietary patterns: a systematic review. Nutr Rev 2014;72(1):1-17.
57. Buckland G, Travier N, Cottet V, et al. Adherence to the mediterranean diet and risk of breast cancer in the European prospective investigation into cancer and nutrition cohort study. Int J Cancer 2013;132(12):2918-27.

Author Information

Georgios Anthimidis, MD, MSc.
General Surgeon, 1st Surgical Clinic, Hippokration General Hospital
Thessaloniki, Greece
anthimid@gmail.com

Christophoros Kosmidis
Α΄ Propedeutic Surgical Clinic, Aristotle University of Thessaloniki, Medical School, AHEPA Hospital
Thessaloniki, Greece

Christoforos Efthimiadis
Α΄ Propedeutic Surgical Clinic, Aristotle University of Thessaloniki, Medical School, AHEPA Hospital
Thessaloniki, Greece

Kalliopi Vasiliadou
Α΄ Propedeutic Surgical Clinic, Aristotle University of Thessaloniki, Medical School, AHEPA Hospital
Thessaloniki, Greece

Georgia Ioannidou
Radiologic Department, Agios Pavlos Hospital of Thessaloniki
Thessaloniki, Greece

Basilios Papaziogas
2nd Department of Surgery, Aristotle University of Thessaloniki, Medical School, G. Gennimatas General Hospital
Thessaloniki, Greece

Epameinondas Fahantidis
Α΄ Propedeutic Surgical Clinic, Aristotle University of Thessaloniki, Medical School, AHEPA Hospital
Thessaloniki, Greece

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy

Close

Enter the site

Login

Password

Remember me

Forgot password?

Login

SIGN IN AS A USER

Use your account on the social network Facebook, to create a profile on BusinessPress